Axxcess Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,941
Closed -$216K 1066
2025
Q3
$216K Buy
+3,941
New +$197K ﹤0.01% 866
2025
Q1
Sell
-3,676
Closed -$207K 874
2024
Q4
$207K Buy
3,676
+110
+3% +$6.84K 0.01% 812
2024
Q3
$243K Buy
+3,566
New +$201K 0.01% 768
2024
Q2
Sell
-3,463
Closed -$239K 882
2024
Q1
$239K Hold
3,463
0.01% 749
2023
Q4
$256K Hold
3,463
0.01% 700
2023
Q3
$236K Buy
3,463
+310
+10% +$26.3K 0.01% 674
2023
Q2
$296K Sell
3,153
-3,703
-54% -$289K 0.02% 454
2023
Q1
$465K Sell
6,856
-2,557
-27% -$164K 0.04% 390
2022
Q4
$466K Sell
9,413
-6,417
-41% -$262K 0.04% 367
2022
Q3
$514K Sell
15,830
-293
-2% -$12.1K 0.05% 313
2022
Q2
$635K Buy
16,123
+2,178
+16% +$116K 0.06% 257
2022
Q1
$975K Sell
13,945
-2,114
-13% -$155K 0.08% 221
2021
Q4
$1.25M Buy
+16,059
New +$1.42M 0.09% 177

Other funds holding EXAS

Axxcess Wealth Management's EXAS Position: Q4 2025 in Review

Axxcess Wealth Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 3,941 shares — an estimated $216K sold.

Axxcess Wealth Management first reported a position in EXAS in Q4 2021 and held it in 13 quarters. The position peaked at $1.25M in Q4 2021. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Axxcess Wealth Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Axxcess Wealth Management sold 3,941 Exact Sciences shares in Q4 2025, an estimated $216K.
  • Axxcess Wealth Management first reported a position in Exact Sciences in Q4 2021 and held it in 13 quarters.
  • Axxcess Wealth Management's Exact Sciences position peaked at $1.25M in Q4 2021.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Axxcess Wealth Management's 13F filing for Q4 2025, filed 6 Feb 2026.